Unilateral chronic thromboembolic pulmonary disease associated with combined inherited thrombophilia

Chest

Volumn 121, Issue 1, 2002, Pages 286-289

  Laczika, Klaus ^a   Lang, Irene Martha ^a   Quehenberger, Peter ^a   Mannhalter, Christine ^a   Muhm, Manfred ^a   Klepetko, Walter ^a   Kyrle, Paul Alexander ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Compound inherited thrombophilia; Unilateral thromboembolic pulmonary hypertension

Indexed keywords

HEPARIN; PHENPROCOUMON;

ADULT; ANTICOAGULANT THERAPY; ANTITHROMBIN DEFICIENCY; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ENDARTERECTOMY; FEMALE; GRAFT PATENCY; HETEROZYGOTE; HUMAN; LUNG EMBOLISM; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; PULMONARY HYPERTENSION; THROMBOPHILIA; TREATMENT OUTCOME;

EID: 0036152773     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.121.1.286     Document Type: Article

References (21)

1. Chronic thromboembolic pulmonary hypertension
2. Chronic thrombosis of major pulmonary arteries
3. Surgery for chronic thromboembolic pulmonary hypertension
4. Parallel analysis of tissue-type plasminogen activator and type 1 plasminogen activator inhibitor in plasma and endothelial cells derived from patients with chronic pulmonary thromboemboli
5. Surgical management of unresolved pulmonary embolism: A personal series of 72 patients
6. Mid-term results of pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension
7. Operation for chronic pulmonary thromboembolism accompanied by thrombophilia in 8 patients
8. Thrombotic risk factors in pulmonary hypertension
9. Inherited thrombophilia: Part 1
10. Antithrombin mutation database: 2nd (1997) update; for the coagulation inhibitors subcommittee of the scientific and standardization committee of the international society on thrombosis and hemostasis
11. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
12. Mutation in blood coagulation factor V associated with resistance to activated protein C
13. Experience and results with 150 pulmonary thrombendarterectomy operations over a 29-month period
14. Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coli
15. Unilateral pulmonary artery thrombotic occlusion: Is distal arteriopathy a consequence?
16. Factor V Leiden and fatal pulmonary embolism
17. The mutation G20210->A in the prothrombin gene is a strong risk factor for pulmonary embolism
18. No increased prevalence of the factor V Leiden mutation in chronic major vessel thromboembolic pulmonary hypertension
19. Assessing thrombotic risk
20. Gene-gene and gene-environment interactions determine risk of thrombosis in families with inherited antithrombin deficiency
21. Prevalence of the factor II G20210A mutation in symptomatic patients with inherited thrombophilia